Targeting the microenvironment in solid tumors
- PMID: 29502037
- DOI: 10.1016/j.ctrv.2018.02.004
Targeting the microenvironment in solid tumors
Abstract
Tumorigenesis is a complex and dynamic process involving different cellular and non-cellular elements composed of tumor microenvironment (TME). The interaction of TME with cancer cells is responsible for tumor development, progression and drug resistance. TME consists of non malignant cells of the tumor such as cancer associated fibroblasts (CAFs), endothelial cells and pericytes composing tumor vasculature, immune and inflammatory cells, bone marrow derived cells, and the extracellular matrix (ECM) establishing a complex cross-talk with tumor. These interactions contribute towards proliferation and invasion of the tumor by producing growth factors, chemokines and matrix-degrading enzymes. ECM is a complex system containing macromolecules with distinctive physical, biochemical and biomechanical properties. During tumorigenesis this system is deregulated favoring the generation of tumorigenic microenvironment enhancing tumor-associated angiogenesis and inflammation. An important step of anticancer treatment is the identification of the biological alterations present in TME in order to target these key molecular players. Multitargeted approaches, providing a simultaneous inhibition of TME components, may offer a more efficient way to treat cancer. In this manuscript we overview the function of each components of TME and the treatments targeting the key players.
Keywords: Bone marrow derived cells; Cancer-associated fibroblasts; Endothelial cells; Extracellular matrix; Immune cells; Tumor microenvironment.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Targeting Tumor Microenvironment for Cancer Therapy.Int J Mol Sci. 2019 Feb 15;20(4):840. doi: 10.3390/ijms20040840. Int J Mol Sci. 2019. PMID: 30781344 Free PMC article. Review.
-
DNA methylation in the tumor microenvironment.J Zhejiang Univ Sci B. 2017 May;18(5):365-372. doi: 10.1631/jzus.B1600579. J Zhejiang Univ Sci B. 2017. PMID: 28471108 Free PMC article. Review.
-
Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.Adv Exp Med Biol. 2020;1277:143-158. doi: 10.1007/978-3-030-50224-9_10. Adv Exp Med Biol. 2020. PMID: 33119871
-
[Tumor microenvironment: promising therapeutic target].Nihon Rinsho. 2015 Aug;73(8):1283-7. Nihon Rinsho. 2015. PMID: 26281679 Review. Japanese.
-
MicroRNAs in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1277:1-31. doi: 10.1007/978-3-030-50224-9_1. Adv Exp Med Biol. 2020. PMID: 33119862 Review.
Cited by
-
A sequentially triggered DNA nanocapsule for targeted drug delivery based on pH-responsive i-motif and tumor cell-specific aptamer.Front Bioeng Biotechnol. 2022 Aug 25;10:965337. doi: 10.3389/fbioe.2022.965337. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36091462 Free PMC article.
-
Bone Microenvironment and Osteosarcoma Metastasis.Int J Mol Sci. 2020 Sep 23;21(19):6985. doi: 10.3390/ijms21196985. Int J Mol Sci. 2020. PMID: 32977425 Free PMC article. Review.
-
Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.Dis Markers. 2022 Sep 2;2022:1014347. doi: 10.1155/2022/1014347. eCollection 2022. Dis Markers. 2022. PMID: 36097539 Free PMC article.
-
Targeted Mass Spectrometry Reveals Interferon-Dependent Eicosanoid and Fatty Acid Alterations in Chronic Myeloid Leukaemia.Int J Mol Sci. 2023 Oct 24;24(21):15513. doi: 10.3390/ijms242115513. Int J Mol Sci. 2023. PMID: 37958498 Free PMC article.
-
Application of single-cell sequencing to the research of tumor microenvironment.Front Immunol. 2023 Oct 27;14:1285540. doi: 10.3389/fimmu.2023.1285540. eCollection 2023. Front Immunol. 2023. PMID: 37965341 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources